Guided Therapeutics (GTHP) Preferred Stock Liabilities (2013 - 2021)
Guided Therapeutics (GTHP) posted Preferred Stock Liabilities of $50000.0 for Q2 2021, down 60.0% sequentially from $125000.0 in Q1 2021.
Guided Therapeutics (GTHP) Preferred Stock Liabilities (2013 - 2021) Analysis & Trends
Guided Therapeutics has reported Preferred Stock Liabilities for 8 years, with the latest figure at $50000.0 in Q2 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $50000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $50000.0 (changed N/A YoY) and the FY2019 annual result came in at $105000.0, changed 0.0% from the prior year.
- Preferred Stock Liabilities fell to $50000.0 in Q2 2021 per GTHP's latest filing, from $125000.0 in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $701000.0 in Q1 2017 and troughed at $50000.0 in Q2 2021.
- A 4-year average of $306000.0 and a median of $125000.0 in 2021 frame the typical range for Preferred Stock Liabilities.
- The sharpest annual moves came in 2018 and 2019: Preferred Stock Liabilities plunged 70.42% in 2018, then changed 0.0% in 2019.
- Over 4 years, Preferred Stock Liabilities stood at $355000.0 in 2017, then slumped by 70.42% to $105000.0 in 2018, then changed by 0.0% to $105000.0 in 2019, then sank by 52.38% to $50000.0 in 2021.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $50000.0, $125000.0, and $105000.0 for Q2 2021, Q1 2021, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 125,000.00 |
| Dec 31, 2019 | 105,000.00 |
| Dec 31, 2018 | 105,000.00 |
| Dec 31, 2017 | 355,000.00 |
| Jun 30, 2017 | 701,000.00 |
| Mar 31, 2017 | 701,000.00 |
| Dec 31, 2016 | 601,000.00 |
| Sep 30, 2016 | 701,000.00 |
| Dec 31, 2015 | 2.05 Mn |
| Jun 30, 2015 | 678,000.00 |
| Mar 31, 2015 | 678,000.00 |
| Dec 31, 2014 | 678,000.00 |
| Sep 30, 2014 | 678,000.00 |
| Jun 30, 2014 | 813,000.00 |
| Mar 31, 2014 | 922,000.00 |
| Dec 31, 2013 | 1.14 Mn |
| Sep 30, 2013 | 1.30 Mn |